Clinical evaluation of xylazine as a chemical restraining agent, sedative, and analgesic in horses.
D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects; D000772:Anesthesia, Local; D000814:Aniline Compounds / Q000008:administration & dosage; D000818:Animals; D004341:Drug Evaluation; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006734:Horse Diseases / Q000601:surgery; D006736:Horses; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D007103:Immobilization; D007275:Injections, Intravenous; D007441:Intubation, Gastrointestinal / Q000662:veterinary; D007828:Laryngoscopy / Q000662:veterinary; D008297:Male; D012119:Respiration / Q000187:drug effects; D013843:Thiazines / Q000008:administration & dosage; D014947:Wounds and Injuries / Q000601:surgery / Q000662:veterinary; D014992:Xylenes / Q000008:administration & dosage
D000700:Analgesics; D000814:Aniline Compounds; D006993:Hypnotics and Sedatives; D013843:Thiazines; D014992:Xylenes